Form 4: Director Waded Cruzado Receives Goosehead Stock Options
Statement of Changes in Beneficial Ownership
Goosehead Insurance director Waded Cruzado was granted 13,979 stock options as part of standard equity compensation.
Summary
- Director Waded Cruzado was granted 13,979 stock options to purchase Class A Common Stock.
- The options have an exercise price of $42.46 per share.
- The grant date is May 5, 2026, with an expiration date of May 5, 2036.
- Vesting occurs in 12 equal quarterly installments over a three-year period, subject to continued service.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that carries no significant signal regarding company performance.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- The grant results in potential future dilution for existing shareholders upon exercise.
Risks
- Vesting is contingent upon continued service, which could be impacted by unforeseen changes in board composition.
Future Outlook
The options vest over a three-year period, incentivizing the director's continued tenure and focus on long-term company performance.
Industry Context
StockSavvy.ai notes that equity grants to independent directors are a standard corporate governance practice in the insurance sector to ensure board members are incentivized to oversee long-term growth and risk management.
Comparison to Industry Standards
- The three-year vesting schedule is consistent with standard equity compensation practices for public company directors.
- The use of stock options as a retention and alignment tool is common among mid-cap financial services firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Waded Cruzado appointed Martin Thornthwaite and Mark E. Jones, Jr. as attorneys-in-fact for SEC filings. | 05/05/2026 | Standard administrative procedure to ensure timely compliance with Section 16 reporting requirements. |
Stakeholder Impact
- Shareholders: Minor dilution impact upon future exercise of options.
- Director: Increased financial alignment with the company's stock performance.
Next Steps
- Quarterly vesting of options beginning three months after the grant date.
Key Dates
| Date | Description |
|---|---|
| 05/05/2026 | Grant date of stock options and date of Power of Attorney execution. |
| 05/07/2026 | Filing date of the Form 4. |
| 05/05/2036 | Expiration date of the granted stock options. |
Keywords
Goosehead Insurance, GSHD, Stock Options, Director Compensation, Insider Transaction, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.